• Parkinson’s Research

  Study Says Parkinson’s Therapies Targeting LRRK2 May Benefit Most Patients

  Posted by Forum Moderator on August 2, 2018 at 6:04 pm

  The LRRK2 gene may play an important role in all types of Parkinson’s, not just the familial form as previously thought, meaning therapies targeting the gene may benefit most patients.

  Read more about this gene and its role, here: Therapies Targeting LRRK2 Gene Could Benefit Broad Population of Parkinson’s Patients, Study Finds

  What do you think about this news? Does it impact you directly?

  replied 5 years, 9 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply